학술논문

The impact of exposure to biomass smoke versus cigarette smoke on inflammatory markers and pulmonary function parameters in patients with chronic respiratory failure
Document Type
Academic Journal
Source
International Journal of Chronic Obstructive Pulmonary Disease. Annual, 2018, Vol. 13, p1261, 7 p.
Subject
Medical research -- Analysis
Smoking -- Care and treatment -- Analysis
Lung diseases -- Care and treatment -- Analysis
Medical records -- Analysis
C-reactive protein -- Analysis
Respiratory insufficiency -- Care and treatment -- Analysis
Blood gas analysis -- Analysis
Spirometry
Women
Lymphocytes
Lung volume measurement
Inflammation
Pulmonary function tests
Respiratory tract diseases
Language
English
ISSN
1178-2005
Abstract
Purpose: The aim of this study was to evaluate the impact of exposure to biomass smoke vs cigarette smoke on serum inflammatory markers and pulmonary function parameters in patients with chronic respiratory failure (CRF). Patients and methods: A total of 106 patients with CRF divided into age and gender-matched groups of cigarette-smoke exposure (n=55, mean [SD] age: 71.0 [12.0] years, 92.7% were females) and biomass smoke exposure (n=51, mean [SD] age: 73.0 [11.0] years, 94.1% were females) were included in this retrospective study. Data on patient demographics (age and gender), inflammatory markers, including neutrophil-to-lymphocyte ratio, C-reactive protein, platelet/mean platelet volume ratio, arterial blood gas analysis, and pulmonary function test findings, including forced expiratory volume in 1 second (FE[V.sub.1]), forced vital capacity (FVC), and FE[V.sub.1]/FVC were obtained from medical records. Results: Carbon dioxide partial pressure levels were significantly higher in the biomass smoke exposure than in the cigarette smoke exposure group (mean [SD] 51.0 [8.0] vs 47.0 [8.0] mmHg, p=0.026, respectively). Spirometry revealed similarly low levels for FE[V.sub.1] (%) (38.0 [16.0] vs 40.0 [12.0]%) and FVC (%) (45.0 [19.0] vs 39.0 [19.0]%) in cigarette-smoke and biomass smoke exposure groups, whereas biomass smoke exposure was associated with significantly higher FE[V.sub.1]/FVC (75.0 [14.0] vs 58.0 [12.0]%, p=0.001), lower FVC (mL) (mean [SD] 744.0 [410.0] vs 1,063.0 [592.0] mL, p=0.035) and lower percentage of patients with FE[V.sub.1]/FVC Conclusion: Our findings indicate similarly increased inflammatory markers and abnormally low pulmonary function test findings in both biomass smoke exposure and cigarette smoke exposure groups, emphasizing the adverse effects of biomass smoke exposure on lungs to be as significant as cigarette smoke exposure. Association of biomass smoke exposure with higher likelihood of FE[V.sub.1]/FVC ratio of >70% and more prominent loss of vital capacity than cigarette smoke exposure seems to indicate the likelihood of at least 18 years of biomass exposure to be sufficiently high to be responsible for both obstructive and restrictive pulmonary diseases. Keywords: biomass exposure, cigarette smoke, inflammatory markers, spirometry, chronic respiratory failure
Introduction Biomass fuels refer to any plant (eg, wood) or animal-based material (eg, dung and crop residues) deliberately burned by humans as their main source of domestic energy for cooking, [...]